Moreover, to ascertain how CNV impacted the expression of SLC24A3 among CESC patients, we compared the SLC24A3-expressed levels between CNV amplification mutations, deletion mutations, and normal samples and showed that the CNV amplification mutations was significantly increased in CESC (Figure 3(f)). The gene discussed is SLC24A3; the disease is cervical squamous cell carcinoma.